Warwick Smith - Articles and news items


BGMA response to Branded Medicines Consultation

Industry news / 30 January 2015 / British Generic Manufacturers’ Association (BGMA)

Warwick Smith, Director General of the BGMA, has welcomed the DofH’s decision not to introduce an additional price cut for branded generic medicines…


Branded generics need statutory exemption

Industry news / 13 November 2014 / British Generic Manufacturers Association

Price cuts for branded generic medicines as part of proposed Government changes to the statutory scheme to control the prices of branded health service medicines will undermine innovation, create uncertainty, reduce competition and ultimately undermine patient benefits…


Generic usage remains crucial to NHS savings and promoting innovation

Industry news / 7 November 2014 / The British Generic Manufacturers Association

Response from the British Generic Manufacturers Association (BGMA) to a new report issued today by the Academy of Medical Royal Colleges…

BGMA welcomes EU General Court ruling that AstraZeneca abused its dominant position by preventing the marketing of generic omeprazole

Industry news, News / 1 July 2010 / College Hill on behalf of BGMA

Commenting on the EU General Court’s ruling that AstraZeneca had acted anti-competitively to…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...